# Depression in Alzheimer's Disease-2

> **NCT00086138** · PHASE2,PHASE3 · COMPLETED · sponsor: **Johns Hopkins University** · enrollment: 131 (actual)

## Conditions studied

- Alzheimer's Disease
- Depression

## Interventions

- **DRUG:** Sertraline (Zoloft)
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00086138
- **Lead sponsor:** Johns Hopkins University
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-07
- **Primary completion:** 2008-07
- **Final completion:** 2009-07
- **Target enrollment:** 131 (ACTUAL)
- **Last updated:** 2017-04-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00086138

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00086138, "Depression in Alzheimer's Disease-2". Retrieved via AI Analytics 2026-06-27 from https://api.ai-analytics.org/clinical/NCT00086138. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*